Universal Fixed Meal Boluses Usage in Patients With Medtronic Minimed 780G Pumps

NCT06372392 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2024-04-18

No results posted yet for this study

Summary

Cross-over study of 20 pediatric patients (age 7-19) randomized to the group receiving universal fixed meal boluses coefficients (300/TDD for breakfast and 400/TDD other meal) or to the group with individualized coefficients for the period of 14 days with consecutive analysis of the results from Carelink Raport.

Conditions

  • Type1diabetes

Interventions

DEVICE

Universal meal coefficient utilization

Usage of universal fixed meal bolus coefficients for the control of postprandial hyperglycemia compared to individualized coefficients n the users of Medtronic Minimed 780G pumps

Sponsors & Collaborators

  • Estonia Research Council

    collaborator UNKNOWN
  • Tartu University Hospital

    lead OTHER

Principal Investigators

  • Aleksandr Peet · Tartu University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
7 Years
Max Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-10
Primary Completion
2024-06-10
Completion
2024-12-01
FDA Device
Yes

Countries

  • Estonia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06372392 on ClinicalTrials.gov